Sulzer hip implant settlement progress marred by Texas verdict
This article was originally published in Clinica
Executive Summary
Swiss company Sulzer Medica has hit out at a $15.1 million verdict against its Sulzer Orthopedics division in favour of three women who underwent revision surgery after receiving a faulty hip implant made by the company. It argues that its own proposed settlement plan represents the best solution for all patients. The company also said the verdict was "totally out of line for this case and it will not stand on appeal".